We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
High tumor budding predicts a poor prognosis in resected duodenal adenocarcinoma.
- Authors
Sakaguchi, Tatsuma; Satoi, Sohei; Hashimoto, Daisuke; Yamamoto, Tomohisa; Yamaki, So; Hirooka, Satoshi; Ishida, Mitsuaki; Ikeura, Tsukasa; Inoue, Kentaro; Naganuma, Makoto; Ishikawa, Hideki; Sekimoto, Mitsugu
- Abstract
Purpose: Tumor budding is a histological characteristic defined as the presence of small clusters of cancer cells at the invasion front. Its significance in duodenal adenocarcinoma (DA) has not been fully described. Methods: A single-center, retrospective study was conducted. Patients who underwent curative surgery for histologically diagnosed DA from January 2006 to December 2018 at Kansai Medical University Hospital were included. Tumor budding was counted per 0.785 mm2 and classified as low (0–4 buds), intermediate (5–9 buds), or high (≥ 10 buds). Results: In total, 47 patients were included. The 5-year overall survival and relapse-free survival rates were 77% and 72%, respectively. High tumor budding was seen in 15 patients (32%). Excluding patients with superficial type (pT1) DA (n = 22), high tumor budding [hazard ratio (HR) 13.4, p = 0.028], regional lymph node metastasis (HR 19.9, p = 0.039), and adjuvant chemotherapy (HR 0.056, p = 0.036) were independent factors related to the overall survival in multivariate analyses. Distant metastases occurred significantly more often in patients who had high tumor budding than in others (p = 0.039). Conclusion: The data suggest that high tumor budding is a predictor of a poor prognosis in resected DA.
- Subjects
TUMOR budding; DUODENAL tumors; LYMPHATIC metastasis; ADENOCARCINOMA; OVERALL survival; PROGNOSIS
- Publication
Surgery Today, 2022, Vol 52, Issue 6, p931
- ISSN
0941-1291
- Publication type
Article
- DOI
10.1007/s00595-021-02433-z